ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Bushes Restate Commitment to Dialogue

August 8, 2003

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

April 27, 2007

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

CALG Loses Pediatrics Grant

July 20, 1979

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

January 27, 2006

Major League Baseball Begins Struggle to Eject Ever-Present Smokeless Tobacco Forom The Sport

April 12, 1991